Annual report pursuant to Section 13 and 15(d)

Acquisition of Emerald Health Therapeutics, Inc - Assumptions to Value Options (Details)

v3.23.1
Acquisition of Emerald Health Therapeutics, Inc - Assumptions to Value Options (Details)
12 Months Ended
Nov. 10, 2022
Dec. 31, 2022
Dec. 31, 2021
Minimum      
Asset Acquisition [Line Items]      
Expected term (years)   5 years 5 years 3 months 7 days
Maximum      
Asset Acquisition [Line Items]      
Expected term (years)   6 years 29 days 6 years 1 month 17 days
Emerald Health Therapeutics Inc | Employee Stock      
Asset Acquisition [Line Items]      
Dividend yield 0.00%    
Volatility, minimum 76.61%    
Volatility, maximum 126.45%    
Risk-free interest rate, minimum 3.51%    
Risk-free interest rate, maximum 4.56%    
Emerald Health Therapeutics Inc | Employee Stock | Minimum      
Asset Acquisition [Line Items]      
Expected term (years) 7 days    
Emerald Health Therapeutics Inc | Employee Stock | Maximum      
Asset Acquisition [Line Items]      
Expected term (years) 4 years 9 months 29 days